Store

Home
UCB Pharma S.A.
Braine-L'Alleud Feb 2022 483R

483R Document: UCB Pharma S.A., Feb 4, 2022

Wayne E. Seifert, FDA Investigator
Roger F. Zabinski, FDA Investigator

FDANews 483R UCB Pharma S.A. Feb 4 2022 top

Wayne E. Seifert FDA Investigator Roger F. Zabinski FDA Investigator

FDA inspected UCB Pharma S.A.'s Braine-L'Alleud site on Feb 04, 2022. See how they responded.

UCB Pharma S.A.

483R Document

Issued: Feb 4, 2022

Details

Human DrugsInspection
Braine-L'Alleud / Belgium
9 days

Available for Download - $299

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.